2015
DOI: 10.12809/hkmj144402
|View full text |Cite
|
Sign up to set email alerts
|

Aetiological bases of 46,XY disorders of sex development in the Hong Kong Chinese population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 16 publications
1
10
0
1
Order By: Relevance
“…Previous functional analyses suggest that NR5A1 p.Arg92Trp cannot activate testicular development via male pathway genes including Sox9 , Amh , and Cyp11a1 (Bashamboo et al., ). Instead these variants lose male‐pathway regulatory ability, this is consistent with the fact that these variants have also been described in 46,XY DSD (Bashamboo et al., ; Chan et al., ) where activation of testis differentiation is lost and ovarian development takes over. Consistent with these results, we found that neither the p.Arg92Trp variant nor the novel p.Ala260Val variant had increased SOX9 activation, thus in vitro there is no evidence for NR5A1 variants abnormally activating the testis pathway.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…Previous functional analyses suggest that NR5A1 p.Arg92Trp cannot activate testicular development via male pathway genes including Sox9 , Amh , and Cyp11a1 (Bashamboo et al., ). Instead these variants lose male‐pathway regulatory ability, this is consistent with the fact that these variants have also been described in 46,XY DSD (Bashamboo et al., ; Chan et al., ) where activation of testis differentiation is lost and ovarian development takes over. Consistent with these results, we found that neither the p.Arg92Trp variant nor the novel p.Ala260Val variant had increased SOX9 activation, thus in vitro there is no evidence for NR5A1 variants abnormally activating the testis pathway.…”
Section: Discussionsupporting
confidence: 83%
“…The NR5A1 p.Ala260Val variant was extremely rare in the population (gnomAD frequency: 4.13e‐6) and predicted to be damaging in two of the four in silico algorithms used. It has been previously implicated in 46,XY DSD (Chan et al., ). These two NR5A1 variants were found in heterozygous form and flagged for functional validation.…”
Section: Resultsmentioning
confidence: 97%
“…This mutation yields impaired 5 α‐reductase activity as a consequence of reduced NADPH binding capacity (Mendonca et al, ). The p.Asn193Ser mutation was first reported in an Iranian 5‐alpha‐reductase deficiency type 2 patient and has also been previously reported in Spanish (Fernández‐Cancio et al, ), Polish (Boudon et al, ; Fénichel et al, ), Chinese (Chan et al, ; Cheng et al, ; Fernández‐Cancio et al, ), African, Brazilian (Maimoun et al, ) and Mexican‐Mestizo (Vilchis et al, ) families. To date, around 130 different mutations have been described in the SRD5A2 gene causing 5‐alpha‐reductase type 2 deficiency.…”
Section: Discussionmentioning
confidence: 68%
“…With any clinical picture consisting of genital anomalies at birth, renal symptomatology (facial edema, proteinuria and high blood pressure) during childhood and the diagnosis of renal failure during adolescence, rare genetic nephropathies, such as Frasier syndrome and Dennis Drash syndrome, must be considered. (7,20,23,24). In low-income settings such as ours, where genetic technology is not always available, the diagnosis of Frasier syndrome should be considered in any child with developmental abnormalities of the external genitalia presenting with isolated proteinuria and/or signs of impaired renal function during childhood or adolescence.…”
Section: Discussionmentioning
confidence: 99%